Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2025-12-24 @ 12:00 PM
NCT ID:
NCT02885961
Eligibility Criteria:
Inclusion Criteria:
* A diagnosis of IPF based on multi disciplinary meeting discussion following review of the clinical history, characteristic features on HRCT (high resolution CT scan) and/or usual interstitial pneumonia (UIP) histology.
* Written informed consent obtained from subject.
Exclusion Criteria:
* Age \<40 or \>80 years
* Renal impairment as defined by a creatinine clearance of \<30 millilitres/min
* Significant liver impairment with evidence of synthetic dysfunction
* Any contraindication to anti-coagulation including previous life threatening or serious bleed or bleeding tendency.
* Co-administration of any concomitant medications prohibited in full protocol. N-acetyl cysteine, prednisolone up to 10mg daily and pirfenidone are permitted.
* Pregnant, breast feeding or unwilling to practice birth control during participation in the study (females of child bearing age).
* Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient of the quality of the data.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT02885961
Study Brief:
Protocol Section:
NCT02885961